CMN1 Stock Chart & Stats
Currently, no data available
Please return soon. This page is being updated.
Bulls Say, Bears Say
Bulls Say
Improved Profitability & ROESustained improvement in margins and a ROE of 12.62% indicate the company is extracting higher value from sales and capital. For a defense supplier this implies durable operational discipline, pricing power on specialized products and improving returns that support reinvestment and long-term shareholder value.
Manageable LeverageA debt-to-equity around 0.40 and a ~44% equity ratio provide financial flexibility to fund program bids, working capital and selective M&A without overleveraging. This balance sheet structure reduces refinancing risk across multi-year defense contract cycles and supports stability through procurement variability.
Contracted, Recurring Revenue ModelChemring's mix of expendables, platform replenishment and long-term support services creates recurring revenue streams and installed-base aftermarket demand. That business model smooths revenue over program lifecycles and supports predictable service revenues and spare-parts margins over the medium term.
Bears Say
Declining Revenue GrowthA mid-single-digit revenue decline is structurally meaningful for a defense OEM reliant on program volumes. If program timing, export wins or renewals do not reverse this trend, revenue erosion can compress absolute scale, reduce operating leverage benefits and limit long-term investment capacity.
Deteriorating Free Cash FlowA steep fall in free cash flow creates persistent funding risk: it can constrain capex, make contract performance financing harder, and increase reliance on external funding. Over months this weakens the company’s ability to self-fund growth, support working capital, and maintain shareholder distributions.
Customer & Budget Concentration RiskHeavy reliance on government procurement and a few key defence customers makes revenues lumpy and sensitive to budget cycles and award timing. This concentration increases downside if defence spending shifts, competitive procurements are lost, or renewals are delayed over the medium term.
Chemring News
CMN1 FAQ
What was Chemring’s price range in the past 12 months?
Currently, no data Available
What is Chemring’s market cap?
Chemring’s market cap is CHF1.74B.
When is Chemring’s upcoming earnings report date?
Chemring’s upcoming earnings report date is Dec 15, 2026 which is in 129 days.
How were Chemring’s earnings last quarter?
Chemring released its earnings results on Jun 02, 2026. The company reported CHF0.066 earnings per share for the quarter, the consensus estimate of CHF0.066 by CHF0.
Is Chemring overvalued?
According to Wall Street analysts Chemring’s price is currently Undervalued.
Does Chemring pay dividends?
Chemring does not currently pay dividends.
What is Chemring’s EPS estimate?
Chemring’s EPS estimate is 0.14.
How many shares outstanding does Chemring have?
Chemring has 272,126,800 shares outstanding.
What happened to Chemring’s price movement after its last earnings report?
Chemring reported an EPS of CHF0.066 in its last earnings report, expectations of CHF0.066. Following the earnings report the stock price went same N/A.
Which hedge fund is a major shareholder of Chemring?
Currently, no hedge funds are holding shares in CH:CMN1
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Chemring Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
CHF6.92 (― Upside)
CHF6.92 (― Upside)
Insider Transactions
Sold Shares
Worth CHF1.4M over
the Last 3 Months
the Last 3 Months
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Positive
20 days / 200 days
Momentum
47.50%
12-Months-Change
Fundamentals
Return on Equity
1.36%
Trailing 12-Months
Asset Growth
20.26%
Trailing 12-Months
Company Description
Chemring
Chemring Group Plc engages in the manufacture of technology products and services for the aerospace, defense, and security markets. It operates through the following segments: Sensors & Information; and Countermeasures & Energetics. The Sensors & Information segments provides consulting and technology services to solve security-critical issues. The Countermeasures & Energetics segment comprises of development and manufacture of expendable countermeasures for air and sea platforms, cartridge and propellant actuated devices, pyrotechnic devices for satellite launch and deployment, missile components, propellants, separation sub-systems, actuators, and energetic materials. The company was founded on November 30, 1905 and is headquartered in Romsey, the United Kingdom.